Posts tagged ‘NYSE:BDX’
Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
Company Also Reduces Size of Board of Directors from Eight to Five and Announces Change in Board Membership, Including the Appointment of Life Sciences Industry Veteran Vito Mangiardi and Wall Street Veteran Kevin Pollack Pressure BioSciences Inc. (OTCQB: PBIO), a developer of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology (“PCT”), operating in the same
Pressure BioSciences (PBIO) Announces Strategic Partnership with LEAP Technologies
Pressure BioSciences Inc. (OTCQB: PBIO), a developer of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology (“PCT”), operating in the same industry as companies like Qiagen NV (NASDAQ: QGEN) and Becton, Dickenson and Co. (NYSE: BDX), recently announced a strategic co-development, co-marketing and co-selling agreement with well known LEAP Technologies, which is focused
Sample Preparation: A Rapidly Growing Industry
Pressure BioSciences Inc. (OTCQB: PBIO), a developer of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology (“PCT”), operating in the same industry as companies like Qiagen NV (NASDAQ: QGEN) and Becton, Dickenson and Co. (NYSE: BDX), recently announced a non-exclusive, worldwide, royalty-bearing license agreement. An Important & Growing Market Sample preparation before
Accelr8 (AXK): Award-Winning Technology Could Unlock Tremendous Value
Accelr8 Technology Corporation (AMEX: AXK), a developer of innovative materials and instrumentation to rapidly identify infectious pathogens, operating in the same basic industry as companies like PolyMedix Inc. (OTCBB: PYMX) and Becton Dickinson and Co. (NYSE: BDX), appears well positioned to unlock significant value over the long-term. Fighting a Common Problem in Hospitals Many people
Pressure BioSciences (PBIO): A Game-Changing Technology Platform
Pressure BioSciences Inc. (NASDAQ: PBIO) is a developer of proprietary laboratory instrumentation and associated consumables based on its game-changing Pressure Cycling Technology (PCT), competing against other companies in the sample preparation technology sector, like Qiagen NV (NASDAQ: QGEN) and Becton, Dickenson and Co. (NYSE: BDX). Simplifying and Improving Sample Preparation Lab sample preparation is often